Entyvio (vedolizumab)

An integrin receptor antagonist called ENTYVIO is prescribed to 

• adults for the management of moderately to highly active ulcerative colitis.  
• Crohn’s disease that is moderately to severely active. 

Recommended Dosage

• Take ENTYVIO as your doctor prescribes it. For adults with ulcerative colitis (UC) or Crohn’s disease (CD), the typical dosage is 300 mg. Your doctor will administer this through an IV infusion over about 30 minutes. You’ll receive it at zero, two, and six weeks, then every eight weeks afterward.
• If you don’t feel better after 14 weeks of treatment, your doctor may stop giving you ENTYVIO.
• Before using ENTYVIO, it’s mixed with special liquids like Sterile Water for Injection or Sodium Chloride Injection. It’s diluted further with Sodium Chloride Injection or Lactated Ringer’s Injection before it’s given to you. Your doctor will have detailed instructions on how to prepare and store it.
• Make sure you’re up to date with all your vaccines before starting ENTYVIO. This helps keep you protected according to current immunization guidelines. Always follow your doctor’s advice and ask any questions you have about your treatment.

• If you have serious reactions like severe allergies or infusion-related issues while taking ENTYVIO, tell your doctor. They may need to stop your treatment and give you different care.
• If you have a strong infection, it’s better to wait until it gets better before starting or continuing ENTYVIO. Your doctor might stop ENTYVIO if you get a serious infection while taking it.
• Though rare, there might be a small chance of a brain condition called PML. Your doctor will watch out for any new or worsening signs in your nerves or brain while you’re on ENTYVIO. Always let your doctor know about any changes you notice.

 If you are considering the import of Entyvio (vedolizumab)  to India, please be aware that Entyvio can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:

Required Documentation for Import:

• A valid prescription from a qualified medical practitioner.
• Diagnostic reports of the patient.
• Government-issued identification proof for the patient, as recognized by the Government of India.

Order Confirmation Process: 

The order for Entyvio will be confirmed upon the receipt of the following documents:

• A valid prescription from a qualified doctor.
• An import permit, if applicable.

Availability of Entyvio in India: 

Entyvio (vedolizumab) is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.

Entyvio (vedolizumab) can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.

IPN (Indian Pharma Network) is dedicated to facilitating the supply of Entyvio (vedolizumab) (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.

For inquiries regarding the price of Entyvio (vedolizumab) in India and to initiate the ordering process, please reach out to us through the following contact details:

Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe

Indian Pharma Network is proficient in sourcing Entyvio (vedolizumab) from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.